TAIPEI, Taiwan, Sept. 12, 2017 -- Success Entertainment Group International Inc. (Other OTC:SEGN) announced that on August 22, 2017, the Company appointed V Stock Transfer, LLC as its new stock transfer agent.
This decision was made to enhance the Company’s actions through its transfer agent, as SEGN plans to embark on various activities related to investor relations in the coming months, with the objective of increasing the Company’s trading volume and visibility amongst the investment community. The Company may also evaluate possible stock-based M&A opportunities as it also becomes more active with its activities relating to capital markets and investor outreach.
About Success Entertainment Group International Inc.:
Success Entertainment Group International Inc. (Other OTC:SEGN), is an e-commerce based organization focusing on membership database platform buildup. Our company has been awarded operational IP rights by one of Asia’s prominent inspirational speakers, Steve Chen, through his fans global database. Over the years, Mr. Chen’s Company has accumulated enormous membership data streamlining through to e-commerce and video platforms in Asia, creating substantial revenue. Our strategy for the company is to acquire or partner with platforms alike and apply the aforementioned fans databases, which spreads to the more than 100 million people in consumer population in Asia. Such a revenue stream may contribute viable and steady growth to the Company.
IR Contact:
Success Entertainment Group International, Inc.
www.segnusa.com
Email Contact: [email protected]
Telephone: +1(260) 490-9990


DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
FDA Approves Mitapivat for Anemia in Thalassemia Patients
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Italy Fines Apple €98.6 Million Over App Store Dominance 



